Table 3

Schedule of assessments and data collection

Assessment	At time of consent	Day 1 (face to face)	Day 3 (face to face)	Day 14 (face to face or telephone)	Day 30 (face to face）
Assessment of eligibility	×
Written informed consent	×
Basic information	×
Medication history	×
Physical examination	×		×		×
PCT level	×
CAT score	×				×
mMRC score	×				×
Antibiotic prescription	×	×	×	×	×
Other medicine for AECOPD	×	×	×	×	×
Sputum gram staining and culture	×
Lung function	×				×
Assessment of therapeutic		×	×	×	×
Adverse effects	×	×	×	×	×
Length of hospital stay					×
Mortality					×

AECOPD, acute exacerbation of chronic obstructive pulmonary disease; CAT, COPD assessment test; ; mMRC, modified Medical Research Council.; PCT, procalcitonin.